Lecture 4 - Drug-receptor theory III - antagonists Flashcards

1
Q

What type of drugs are the majority of clinically useful drugs?

A

Antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an antagonist?

A

A drug that prevents the response of an agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What 5 different classes can antagonism be broken down into?

A
  • chemical antagonism
  • pharmacokinetic antagonism
  • physiological antagonism
  • non-competitive antagonism
  • competitive antagonism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is chemical antagonism?

A
  • Molecule binds in a way that the drug can’t bind to its usual receptor in its usual way.
  • Substances combine in solution so that the effects of an active drug lost - i.e. the agonist is chemically altered by the antagonism
  • e.g. inactivation of heavy metals (e.g. mercury, lead and cadmium) who toxicity is reduced with the addition of a chelating agent (e.g. dimercaprol)
  • Monoclonal antibodies can work in a similar way
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is pharmacokinetic antagonism?

A
  • Reduction in amount of absorbed, metabolised or excreted by another.
  • Pharmacokinetics are the mechanisms that control the absorption, metabolism or excretion of a drug
  • change in drug metabolism - e.g. for patients taking warfarin (anti-coagulant and thins blood, reduces risk of heart attack and stroke) have to be careful when treat with some antibiotics as they may stimulate the metabolism of warfarin so reducing its effective concentration in the blood stream. Levels of warfarin need to be carefully regulated.
  • drug-drug interactions are important when looking at pharmacokinetic interactions.
  • stimulation of drug metabolism may reduce the concentration of the drug in their system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is physiological antagonism?

A

The interaction of 2 drugs (agonists) with opposing actions in the body. This is where the 2 agonists are working at 2 different receptors.

Example 1 - Noradrenaline raises arterial blood pressure by acting on the heart (beta 1 receptors) and peripheral blood vessels (alpha 1 receptors), while histamine (H1 receptors) lowers arterial pressure by causing vasodilation

Example 2 - Histamine acting through H2 receptors increases acid secretion in the gut, while omeprazole counteracts this effect by inhibiting the proton pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is non-competitive antagonism?

A

Blocks some steps in the process between receptor activation and response - i.e. doesn’t compete with the agonist for the receptor site, and so is termed non-competitive.

Not necessarily working on the receptor, but on the signalling pathway.

E.g. Verapamil and Nifedipine inhibit L-type calcium channels to cause relaxation of smooth muscle and lowers blood pressure

Ketamine is a non-competitive inhibitor of NMDA (glutamate) receptors. It blocks the channel pores. It binds to somewhere on the receptor that is different to where glutamate (the usual agonist would bind).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a competitive antagonist?

A

Binds to the same site on the receptor as the agonist. You can measure the affinity of a competitive antagonist using bioassays.

Competitive antagonists competes with agonist for occupancy of the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is reversible competitive antagonism?

A

Competitive reversible antagonism can be overcome by increasing agonist concentration - e.g. effects of atropine on response to acetylcholine for guinea-pig ileum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe what happens when there is an increase in antagonist concentration

A

There is a parallel rightward shift in concentration-response (no change in max)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the dose ratio?

A

How many more times agonist is needed in the presence of an antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the dose ratio equation?

A

conc. of agonist in presence of antagonist//conc. of agonist in absence of antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a Schild analysis?

A

can determine the affinity of an antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does a Schild plot show?

A

The relationship between Dose ratio and antagonist concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Schild equation?

A

Dose ratio (DR) = concentration of antagonist/antagonist affinity constant (KD) + 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do you rearrange the dose ratio to get the concentration of antagonist?

A

KD (DR-1) = concentration of antagonist

17
Q

What is pA2?

A

The point at which Schild’s plot crosses the x-axis

18
Q

What does a high pA2 value mean?

A

A high affinity

19
Q

What is the efficacy of a partial agonist?

A

below 1 but above 0

20
Q

What happens when you mix a partial agonist with agonist?

A

right shift on the concentration response curve. Increase concentration of agonist sufficiently leads to maximum response

21
Q

What do partial agonists show?

A

show competitive antagonism

22
Q

Describe the features of irreversible competitive antagonists

A
  • antagonism that cannot be reversed by washing the tissue
  • irreversible antagonism is time-dependent
  • covalent bond forms between 1 or more amino acid in the protein target. As a result, rules of equilibrium don’t apply.
  • e.g. the effects of the alkylating drug DIBENAMINE (1nM) on histamine responses in the guinea-pig ileum
23
Q

How do we achieve a max response when some receptors have been irreversibly bound to?

A

When enough receptors have been irreversibly bound to, the maximum can’t be reached.

The only way to reach the maximum again is to synthesize more proteins